6-mercaptopurine is indicated for the treatment of acute leukaemia. It may be utilised in remission induction and it is particularly indicated for maintenance therapy in:
– acute lymphoblastic leukaemia (ALL);
– acute myelogenous leukaemia (AML).
Mercaptopurine may be used in the treatment of chronic granulocytic leukaemia.
8653total visits,16visits today